Cerenome, Inc.
CNSY· Nasdaq
CNSYCerenome, Inc.
Filed Mar 30, 2020 · 10-K · 90 days after period end · 0001564590-20-014165
derived · Computed from the longer spans the company filed.
| Metric | Q4 2019dderived from reported figures | Q4 2018dderived from reported figures | Q4 2017 | Q4 2016 |
|---|---|---|---|---|
| Revenue | — | $1.42M | $662.00K | $1.47M |
| Net Income | $884.00K | -$2.24M | -$4.29M | -$4.92M |
| EPS Diluted | — | — | -$0.20 | -$0.24 |
Cerenome, Inc. · CIK 1095981 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2019 · filed Mar 30, 2020 · 90 d after period end
